NYSE / NASDAQ · SEC EDGAR
Equity research
Start with company fundamentals. Compare growth and capital returns, then narrow the research to the companies that meet your criteria.
Research preview · Quarterly financial statements · No price quotes · Not financial advice
Example screens
- Best combined rank673Issuers with both EPS acceleration and ROE, highest rank first.
- Profitable growth140ROE at least 15% and revenue growth at least 10%.
- Earnings acceleration846EPS acceleration at or above zero, largest first.
- High return on equity380ROE at least 25%, highest first.
- NYSE only366The same ranking with NYSE listings only.
| Company | Combined rank | EPS acceleration | Revenue growth | ROE | Net margin | Reporting period |
|---|---|---|---|---|---|---|
| KPTIKaryopharm Therapeutics Inc.NASDAQ | — | — | -11.9% | — | -153.3% | 2026-06-30Filed 2026-08-13 |
| KRKROGER CONYSE | — | — | 2.0% | — | — | 2026-08-15Filed 2026-09-18 |
| KRAQKRAKacquisition CorpNASDAQ | — | — | — | — | — | 2026-06-30Filed 2026-08-13 |
| KREFKKR Real Estate Finance Trust Inc.NYSE | — | — | — | -21.9% | — | 2026-09-30Filed 2026-10-28 |
| KRGKITE REALTY GROUP TRUSTNYSE | — | — | -7.2% | — | — | 2026-09-30Filed 2026-10-30 |
| KRMDKORU Medical Systems, Inc.NASDAQ | — | — | 18.2% | -10.1% | -4.0% | 2026-06-30Filed 2026-08-05 |
| KRMNKarman Holdings Inc.NYSE | — | — | 58.2% | 8.8% | 6.3% | 2026-06-30Filed 2026-08-11 |
| KRNYKearny Financial Corp.NASDAQ | — | — | — | 4.7% | — | 2026-06-30Filed 2026-08-21 |
| KROKRONOS WORLDWIDE INCNYSE | — | — | 12.9% | -14.6% | -5.6% | 2026-06-30Filed 2026-08-05 |
| KROSKeros Therapeutics, Inc.NASDAQ | — | — | -100.0% | -31.7% | -553.9% | 2026-06-30Filed 2026-08-03 |
| KRPKimbell Royalty Partners, LPNYSE | — | — | 30.0% | — | — | 2026-06-30Filed 2026-08-07 |
| KRROKorro Bio, Inc.NASDAQ | — | — | -100.0% | -103.3% | -4477.1% | 2026-06-30Filed 2026-08-06 |
| KRSAKorsana Biosciences, Inc.NASDAQ | — | — | — | -131.8% | — | 2026-06-30Filed 2026-08-04 |
| KRSPRice Acquisition Corp 3NYSE | — | — | — | — | — | 2026-06-30Filed 2026-08-11 |
| KRUSKURA SUSHI USA, INC.NASDAQ | — | — | 16.2% | -0.9% | -0.7% | 2026-05-31Filed 2026-07-07 |
| KSCPKnightscope, Inc.NASDAQ | — | — | 228.3% | -152.0% | -217.3% | 2026-06-30Filed 2026-08-12 |
| KSSKOHLS CorpNYSE | — | — | -0.9% | 6.5% | 1.7% | 2026-08-01Filed 2026-09-03 |
| KTCCKEY TRONIC CORPNASDAQ | — | — | — | -69.1% | — | 2026-06-27Filed 2026-09-24 |
| KTTAPasithea Therapeutics Corp.NASDAQ | — | — | — | -42.7% | — | 2026-06-30Filed 2026-08-14 |
| KTWOK2 Capital Acquisition CorpNASDAQ | — | — | — | — | — | 2026-06-30Filed 2026-08-13 |
| KULRKULR Technology Group, Inc.NYSE | — | — | -43.0% | -140.9% | -648.0% | 2026-06-30Filed 2026-08-13 |
| KURAKura Oncology, Inc.NASDAQ | — | — | 36.5% | -612.8% | -384.3% | 2026-06-30Filed 2026-08-12 |
| KUSTKUSTOM ENTERTAINMENT, INC.NASDAQ | — | — | 88.2% | — | — | 2026-06-30Filed 2026-08-14 |
| KVHIKVH INDUSTRIES INC \DE\NASDAQ | — | — | 26.7% | -4.5% | -4.7% | 2026-06-30Filed 2026-08-06 |
| KVYOKlaviyo, Inc.NYSE | — | — | 26.4% | 0.7% | 0.5% | 2026-06-30Filed 2026-08-05 |
How the lists overlap
EPS acceleration is the change in year-over-year quarterly EPS growth, expressed in percentage points. Revenue growth compares matching quarters a year apart. ROE divides four consecutive quarters of net income by equity at the same latest reporting date.
The combined rank averages the EPS acceleration and ROE percentiles among issuers with both metrics. It ranges from 0 to 100 and describes relative position within this covered group. It is not a probability or a performance estimate.
Net margin uses four consecutive quarters with matching revenue and net income. Missing quarters stay unavailable; additive fourth-quarter values may be derived from annual minus nine-month totals known at the filing date. EPS is never derived this way.
What this data covers
Source: SEC EDGAR company facts. Each value must have been filed on or before the displayed as-of date. Reporting periods older than 185 days are excluded.
The current exchange universe includes multiple security types. The screen shows one ticker per issuer with supported US-GAAP facts; it is not a complete historical stock universe. Missing companies and ratios are coverage gaps, not negative assessments.
Snapshots update daily. Close-price series are shown for the companies the BibaMoney price store covers — the coverage line above states how many of the current matches that is, and a card without a series says so instead of drawing a line. Sector metadata and validated price outcomes are not included: no price outcome in this screen has been checked out of sample.
Macro context: the 10Y–3M Treasury curve was non-inverted on 2026-11-05. Source: FRED / Federal Reserve.